Trump's Plan: A 100% Tax on Imported Prescription Drugs – What It Means for You

By Samantha Weigand

President Donald Trump has announced a plan to put a 100 percent tax on certain imported prescription drugs. This means that for every dollar a drug is worth, an extra dollar would be added as a tax when it enters the US. For example, a $50 shipment of insulin would get an extra $50 tax. This new rule aims to encourage drug companies to make their medicines in the US instead of bringing them in from other countries. It's also meant to make the country more secure by relying less on foreign drug makers. This policy could change drug prices, how medicines are made and shipped, and how easily patients can get them. It might lead to more drug factories in the US, but could also make medicines more expensive for people and health insurance companies. In this article, we'll look at:

• What the policy is about, including which drugs are affected and when it starts.

• How it might change drug prices for shoppers, insurance costs, and the role of generic drugs.

• The economic effects on drug companies, trade with other countries, and how it compares to other drug pricing ideas.

• How it could impact the healthcare system, like causing drug shortages or affecting sick patients.

• How drug companies might react, like moving production to the US.

• What it means for global trade and why it's seen as a national security move.

• What the future might hold and other ways to deal with drug prices besides these taxes.

What is Trump's 100% Tax on Prescription Drugs?

This 100 percent tax on prescription drugs is an import fee that matches the full price of certain brand-name and patented medicines. Its goal is to push drug production into the US and reduce how much we depend on other countries. For example, if a special cancer drug costs $200 per dose, it would get an extra $200 tax. This rule changes how we trade drugs, making companies think about building factories in the US to avoid the extra cost.

Trump's 100% DrugTax: What It Means

President Donald Trump's plan for a 100 percent tax on imported brand-name and patented prescription drugs is set to start on October 1, 2025. The main goal is to get drug companies to make more medicines in the US. This tax could double the cost of some imported brand-name drugs, which might lead to higher prices for American shoppers and contribute to overall rising costs.

This information helps explain the main points of the article about when the tax starts, what it covers, and how it might affect consumer prices.

Which Prescription Drugs Will Be Affected?

Here's a look at the types of drugs that would get the 100 percent import tax. Only brand-name and patented drugs are targeted; cheaper generic drugs are not included.

• Brand-Name New Drugs: These are new, patented medicines made by one company, and they will face a 100 percent tax.

• Patented Biologics: These are complex, patented medicines made from living things, and they will also face a 100 percent tax.

• Extended-Patent Drugs: These are brand-name drugs with extra market protection, and they will be subject to a 100 percent tax.

• Generic Drugs: These are cheaper versions of off-patent drugs that work the same, and they will have no tax.

How Can US Factories Avoid the Tax?

Drug companies can avoid paying the full import tax if they build new or expand existing factories in the US that are approved by the FDA. To get this exemption, they need to meet certain rules:

• Build a factory that can make at least 10 million doses of medicine each year.

• Get FDA approval for the factory within three years of the tax starting.

• Produce enough of the drug to cover at least 30 percent of the US demand for it.

If a company meets these conditions, its brand-name or patented drug can enter the US without the extra tax. This strongly encourages companies to bring their production back to the US.

When Will This Tax Start?

The tax will begin on October 1, 2025. Before that, there will be steps like creating official rules, approving new factories, and talking with different groups involved in healthcare.

• Announcement (Late 2024): Details of the plan are released, and the public can share thoughts.

• Setting Up Rules (Early to Late 2025): The FDA creates rules for exemptions and prepares for factory checks.

• Tax Starts (October 1, 2025): The full 100 percent tax begins on covered imported drugs.

• Check-Up (2027): The policy is reviewed to see if it's working, and changes might be made.

How Will Trump's Drug Taxes Affect What You Pay for Medicines?

A big 100 percent import tax would directly double the cost of brand-name and patented medicines when they arrive in the US. This higher cost would then be passed on to drug sellers, hospitals, and eventually to patients through higher out-of-pocket costs and increased health insurance premiums. For example, a brand-name heart medicine imported for $100 would now cost $200 before it even gets to stores.

How Do These Taxes Make Brand-Name Drugs More Expensive?

• Import Cost Doubles – The tax adds 100 percent of the drug's original price.

• Distributor Markups – Companies that distribute drugs will add their own higher costs when selling to pharmacies.

• Hospital Price Changes – Hospitals and clinics will adjust their prices to cover the new costs from the tax.

How Will Higher Drug Prices Affect Healthcare Costs and Insurance?

• Insurance Premiums Go Up – Insurance companies might raise monthly payments by 8–12 percent to cover their higher drug costs.

• Your Share of Costs Increases – What you pay for co-pays and coinsurance could go up, making it harder for insured patients to afford medicines.

• Overall Healthcare Spending – Hospitals and health systems might see their drug budgets go up by 15 percent, which could affect the prices of other services.

These changes would make healthcare less affordable for people with both private and government-sponsored insurance plans.

What Role Do Generic Drugs Play in Keeping Prices Down?

Generic medicines, which are used for 90 percent of US prescriptions, will not be subject to the 100 percent tax. By switching to generics when possible, patients and insurance companies can:

• Cut out-of-pocket costs by 80 percent compared to brand-name versions.

• Reduce budget stress for health plans and companies that manage drug benefits.

• Keep getting necessary medicines for long-term conditions at a lower price.

So, using more generics can help protect against the price increases caused by the new taxes.

What Are the Economic Effects of These Drug Taxes on the US?

A full-value import tax on medicines will change how much drug companies earn, how much they invest in the US, and how we trade with other countries. It will push money towards making drugs in the US while changing how much we import and export.

How Will These Taxes Affect Drug Company Profits and Investment?

Here's how the taxes might affect company profits and where they choose to invest:

• Keep importing drugs: This choice would lead to 100 percent higher production costs and less profit, with little new spending on factories.

• Build a US factory: This would mean no import tax and stable costs, but high initial spending for long-term production ability.

• Mix of foreign and US sources: This approach would involve some tax exposure but spread out risk, with moderate spending and a stronger supply chain.

What Does This Mean for US Trade with Other Countries?

• It could strain trade relationships with big drug exporters like the EU, India, and Switzerland, possibly leading them to put taxes on US goods.

• It could mess up the global supply chains for important drug ingredients, especially since the EU provides 43 percent of these ingredients for US brand-name drugs.

• It might lead to international discussions at the World Trade Organization to sort out how this tax fits with existing trade agreements.

These changes will affect how the US works with other countries on trade.

How Does This Tax Compare to Other Drug Pricing Ideas?

Let's compare this tax to another idea called Most Favored Nation (MFN) pricing:

• 100 Percent Tariff – Directly targets imported drugs, doubles their cost, and encourages companies to make drugs in the US.

• MFN Pricing – Puts a cap on US drug prices, making them similar to the lowest prices in other developed countries. This reduces price differences without adding import taxes.

The tax uses trade rules to change where drugs are made, while MFN pricing uses price comparisons to control costs without changing import flows.

How Will the Taxes Affect US Healthcare and Patient Access to Medicines?

Higher prices and changes in how drugs are supplied will affect hospitals, clinics, and pharmacies, impacting drug availability, insurance coverage, and especially vulnerable patients.

Is There a Risk of Drug Shortages Because of These Taxes?

If importers face double the costs, they might stop bringing in less profitable generic drugs and specialized medicines. This could lead to:

• Shortages – Many drug shortages already involve generics; these new costs could make the problem worse.

• Delivery Delays – Drug distributors might focus on cheaper options, causing temporary shortages of other medicines.

• Access Problems – Smaller healthcare providers, especially in rural areas, might have trouble getting important medicines.

Healthcare Problems and Patient Access with Drug Taxes

The 100 percent tax on brand-name and patented drugs could make existing drug shortages worse and create new problems for patients to get medicines, especially for those without insurance, with poor insurance, or with low incomes. Experts warn that such taxes can disrupt how drugs are supplied, increase costs, and negatively affect patients' ability to get the medicines they need.

This information supports the article's discussion about possible drug shortages, higher healthcare costs, and how certain patient groups might be hit harder.

These problems could make patients sicker and make the healthcare system less efficient.

Which Patients Are Most at Risk from Higher Drug Prices?

Some groups of people are more likely to be hurt by higher drug prices:

• Patients with Long-Term Illnesses – People who need brand-name medicines for life will face much higher ongoing costs.

• Uninsured or Underinsured – If prices double, essential drugs could become impossible to afford for those without good insurance.

• Low-Income Seniors – Older adults on fixed incomes with Medicare Part D might face huge gaps in their coverage.

These groups would carry a much heavier financial and health burden if drug prices go up due to the taxes.

How Might Health Insurance and Coverage Change?

Insurance companies will likely react by:

• Raising yearly premiums by about 8–12 percent to cover their increased drug costs.

• Changing their drug lists to require patients to try cheaper drugs first or get special approval for brand-name drugs.

• Encouraging more people to sign up for high-deductible plans, where patients pay more out-of-pocket before insurance kicks in, as a way to manage drug cost risks.

These changes in coverage show how insurance companies try to stay financially stable, often at the cost of patient convenience and predictable expenses.

How Are Drug Companies Reacting to Trump's 100% Tax Plan?

Facing the possibility of lower profits, major drugmakers are speeding up plans to move manufacturing to the US, find new suppliers, and adjust their prices.

What Are Companies Doing to Move Production to the US and Find New Suppliers?

Drug companies are using four main strategies:

• Building New Factories – Constructing new FDA-approved plants in places like the US Midwest and Southeast.

• Partnering with US Manufacturers – Working with existing US contract manufacturers to make drugs without building their own full factories.

• Changing Ingredient Sources – Developing US-based factories to make key drug ingredients.

• Creating Regional Supply Hubs – Setting up multiple production sites across North America to reduce problems if one area is disrupted.

Which Big Drug Companies Have Announced US Manufacturing Investments?

Several large global companies have promised to invest billions in expanding their US factories:

• Eli Lilly – $6.5 billion for a biologics factory in Houston, Texas

• Genentech – $700 million for a drug packaging site in Holly Springs, North Carolina

• GSK – $1.2 billion for an advanced production plant in the US

• Amgen – $650 million to expand a biologics plant in Juncos, Puerto Rico

How Are Companies Dealing with the Tax and Protecting Their Profits?

Besides moving production, companies are also taking other steps:

• Adjusting Prices – Reworking their wholesale prices to account for the new costs.

• Focusing on Profitable Drugs – Stopping production of less profitable drugs or selling them to companies that make generic versions.

• Cutting Costs – Using efficient manufacturing methods and digital tools to lower the cost of making each drug unit.

Together, these strategies aim to keep profits up while meeting the rules to avoid the tax.

What Are the Global Trade Effects of the US Drug Taxes?

By putting high taxes on medicines, the US is showing it's willing to change trade rules for national security reasons, which is causing different reactions from other countries.

How Do EU-US Trade Agreements Affect This 100% Drug Tax?

Current agreements between the EU and the US usually limit drug taxes to a maximum of 15 percent. This creates a legal problem with the new 100 percent tax. This conflict could lead to:

• The EU is starting a dispute at the World Trade Organization.

• Talks between the US and EU to agree on tax levels or specific drug categories.

• A closer look at the US government's power to impose such taxes and whether it fits with existing promises.

How this disagreement is resolved will determine the actual taxes on drugs coming from the EU.

What Are Other Countries Saying About This?

Major drug-exporting countries have formally complained and threatened to put their own taxes on US goods:

• EU – Pointed to trade agreement limits and started discussions under WTO rules.

• India – Warned it might put similar taxes on US farm products and technology.

• Switzerland & Germany – Stressed how much countries rely on each other for drug supplies and the risk of drug access problems for everyone.

Diplomatic talks will decide if these retaliatory taxes spread beyond medicines.

How Does National Security Play a Role in These Taxes?

The government says this tax is important for national security because it will:

• Make the US less dependent on foreign factories that could be affected by global conflicts.

• Ensure the US always has access to important medicines during worldwide crises.

• Make the supply chain stronger against actions by unfriendly countries.

Making Drugs in the US for National Security

The Trump administration says the drug taxes are necessary for national security. The goal is to rely less on foreign countries for making medicines and to strengthen US supply chains. This policy has already led to big investment promises, with major drug companies pledging billions to expand their manufacturing in the U.S. to avoid the taxes.

This supports the article's explanation of why the taxes are seen as a national security move and how drug companies are responding by investing more in US manufacturing.

So, national security is used both as a reason for the tax and a way to encourage more drug production in the US.

What's Next and What Are Other Ways to Lower Drug Prices?

Looking ahead, people will consider the long-term effects of this tax versus other ways to get affordable, secure drug supplies without broad import taxes.

What Are the Long-Term Effects on the Economy and New Discoveries?

Ongoing pressure from these taxes might:

• Encourage $20–30 billion in new US manufacturing investments each year for a decade.

• Led to new ways of making drugs and digital production methods in the US.

• Risk shrinking research and development budgets as companies spend money on building factories instead.

Finding the right balance between building factories and funding research will determine the overall gains in economic growth and new medical treatments.

What Other Policies Could Lower Drug Prices Without Taxes?

Other ways to make drugs more affordable without import taxes include:

• Value-Based Pricing – Paying for drugs based on how well they work for patients, rather than just their list price.

• Direct Negotiation – Allowing government programs like Medicare to directly negotiate drug prices with manufacturers.

• US Production Credits – Offering tax breaks or grants for making drugs in the US instead of punishing imports with taxes.

Each of these options aims to make drugs more affordable and ensure a steady supply using market forces or financial incentives, rather than trade barriers.

How Might Legal Challenges Affect the Tax?

Lawsuits and negotiations could:

• Delay or reduce the tax on EU imports while international rulings are pending.

• Lead to the tax ending or being extended based on how well the exemptions work.

• Influence Congress to review the policy and possibly change the government's power to impose such taxes.

The outcomes of these legal battles will decide the final scope, length, and details of the tax.

Worried About Prescription Costs?

Get relief from expensive medications!

Visit our Tools Page for resources to help save money and manage medication expenses—take control today!